missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Gibco™ Human ApoE4 Recombinant Protein, PeproTech®
Klik for at se tilgængelige muligheder
Mængde:
100 μg
2 x 500 μg
500 μg
Beskrivelse
350-04-1MG will be provided as 2 x 500 μg (350-04-500UG). Recombinant Human ApoE4 is a 34.4 kDa protein containing 300 amino acid residues. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis
ApoE belongs to a group of proteins that bind reversibly with lipoprotein and play an important role in lipid metabolism. In addition to facilitating solubilization of lipids, these proteins help to maintain the structural integrity of lipoproteins, serve as ligands for lipoprotein receptors, and regulate the activity of enzymes involved in lipid metabolism. Significant quantities of ApoE are produced in the liver and brain, and to some extent in almost every organ. ApoE is an important constituent of all plasma lipoproteins. Its interaction with specific ApoE receptor enables uptake of chylomicron remnants by liver cells, which is an essential step during normal lipid metabolism. It also binds with the LDL receptor (apo B/E). Defects in ApoE are a cause of hyperlipoproteinemia type III. ApoE exists in three major isoforms; E2, E3, and E4, which differ from one another by a single amino-acid substitution. Individuals heterozygous for the ApoE4 allele are at higher risk of late-onset Alzheimer's disease.
Tekniske data
Tekniske data
| Adgangsnummer | P02649 |
| Til brug med (applikation) | Functional Assay |
| Formulering | protein with no preservative |
| Gen-id (Entrez) | 348 |
| Molekylvægt (g/mol) | 34.4 kDa |
| Navn | Human ApoE4 |
| Mængde | 500 μg |
| Kilde | E. coli |
| Regulatorisk status | RUO |
| Endotoksin koncentration | <1 EU/ μg |
| Vis mere |
Korrektion af produktindhold
Dit input er vigtigt for os. Udfyld denne formular for at give feedback relateret til indholdet på dette produkt.
Produkttitel
Ser du en mulighed for forbedring?Del en indholdskorrektion